Chugai Pharmaceutical Co., Ltd. provided consolidated earnings guidance for the first nine months of fiscal year 2020 and full year ending December 31, 2020. For the first nine months, the company expects revenues of JPY 576,520 million, core operating profit of JPY 231,881 million and core net income of JPY 165,629 million or JPY 100.68 per share. For the year, the company expects revenues of JPY 740,000 million, core operating profit of JPY 275,000 million and core net income of JPY 201,000 million or JPY 122.00 per share.